Ultragenyx Pharma (RARE) Misses Q2 EPS by 2c

August 8, 2016 4:32 PM EDT
Get Alerts RARE Hot Sheet
Trade RARE Now!
Join SI Premium – FREE

Get daily under-the-radar research with StreetInsider.com's Stealth Growth Insider Get your 2-Wk Free Trial here.

Ultragenyx Pharma (NASDAQ: RARE) reported Q2 EPS of ($1.46), $0.02 worse than the analyst estimate of ($1.44).

For earnings history and earnings-related data on Ultragenyx Pharma (RARE) click here.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In






Related Categories

Earnings

Related Entities

Earnings

Add Your Comment